“最新突破研究”截稿时间: 2025年1月24日 （仅剩2天）
欢迎登陆大会官方网站踊跃投稿!
https://www.apasl2025beijing.com
APASL 2025 BEIJING allows for the submission of abstracts containing clinical or non-clinical data which were unavailable at the time of the abstract submission deadline. Late breaker submission will be close at 24 January 2025 and notified the results by 17 Feb 2025.
APASL 2010 BEIJING允许提交在投稿截止日期时尚未获取的包含临床或非临床数据的摘要。“最新突破研究” 摘要的提交截止日为 2025 年 1 月 24日，将于 2025 年 2 月 17 日前公布结果通知。
Elimination Forum | 27 MAR 2025
In the forum, updated epidemiology, experience from WHO, different countries and regions will be invited and share with the round table/group discussion topics (included but not limited) as follow:
1. Viral Hepatitis Epidemiology
2. Disease Burden (Prevalence of End-Stage Liver Disease and Mortality Rates)
3. Progress of Elimination of Viral Hepatitis
4. Experience and Challenges
5. Five-Year Action Plan for 2025-2030
We are calling for abstracts specially focusing on the viral hepatitis elimination.
消除肝炎危害经验分享 | 2025 年 3 月 27 日
该会议将介绍最新的流行病学情况并邀请世界卫生组织、不同国家和地区的专家分享经验，同时还会设置圆桌讨论 / 小组讨论话题 。
我们正在征集特别侧重于病毒性肝炎消除的稿件。
We are pleased to announce submitted abstracts were selected for presentation in APASL 2025 BEIJING, the award results and guidelines are expected to be announced before January 28th. The early bird registration fees be extended for Presenting authors accordingly.
VIsit the website https://www.apasl2025beijing.com/result.htmlto check the Abstract Acceptance Notification .
摘要的入选情况已在APASL 2025 BEIJING官网上展示。获奖结果及相关参会指南预计将于 1 月 28 日前公布。相应地，入选摘要稿件的“报告作者”可用早鸟注册费标准注册参会。
请访问https://www.apasl2025beijing.com/result.html查看摘要稿件入选情况。
（来源：APASL会议）
声明：本文仅供医疗卫生专业人士了解最新医药资讯参考使用，不代表本平台观点。该信息不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议，如果该信息被用于资讯以外的目的，本站及作者不承担相关责任。
